<DOC>
	<DOCNO>NCT00783926</DOCNO>
	<brief_summary>The objective study assess dose-related safety immunogenicity six different dose level inactivate , Vero cell-derived reverse genetic reassortant A/H5N1/Indonesia/05/2005 influenza vaccine healthy young adult population . Subjects receive 2 vaccination ( 21 day apart ) dose assign . Blood drawn subject serum antibody determination Days 0 , 21 , 42 180 . Body temperature measure daily 6 day follow vaccination . Injection site reaction systemic reaction monitor throughout entire 180 day study . Safety data obtain 7 day first vaccination dose level Cohort 1 review Data Monitoring Committee recommendation obtain whether proceed second vaccination Cohort 1 first vaccination Cohort 2 .</brief_summary>
	<brief_title>Phase 1 Study H5N1 Influenza Vaccine ( Reverse Genetic Reassortant )</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Hemagglutinins</mesh_term>
	<criteria>Subjects Have understand study , agree provision , give write informed consent prior study entry Are clinically healthy , determine Investigator 's clinical judgment collection medical history performance physical examination Are physically mentally capable participate study Are willing refrain blood donation duration Part A study ( Day 42 [ = 21 day second vaccination ] ) Agree keep daily record symptom duration study If female capable bearing child negative urine pregnancy test result within 24 hour schedule first vaccination agree employ adequate birth control measure duration study . Subjects exclude participation study : Have history exposure H5N1 influenza virus history vaccination H5N1 influenza vaccine Are potential occupational risk contract H5N1 influenza infection ( e.g. , poultry worker ) Suffer history significant neurological , cardiovascular , pulmonary ( include asthma ) , hepatic , rheumatic , autoimmune , hematological , metabolic renal disorder Have Body Mass Index &gt; 35 Have hypertension screen grade great Stage 1 ( define systolic pressure &gt; 159 diastolic pressure &gt; 99 ) seat rest ( measurement shall repeat twice subject exclude ) Have clinically significant abnormal clinical laboratory value screen determine Investigator Have clinically significant electrocardiographic abnormality screen Test positive HIV , HBcAb HCV Suffer kind immunodeficiency Suffer disease undergo form treatment within 30 day study entry currently undergoing form treatment expect influence immune response . Such treatment include , limited , systemic high dose inhale ( &gt; 800Âµg/day beclomethasone dipropionate equivalent ) corticosteroid , radiation treatment immunosuppressive cytotoxic drug Have history severe allergic reaction ( e.g . clinically severe urticaria , allergic rhinitis , asthma ) anaphylaxis ( medical emergency cause acute hypersensitivity reaction involve several organ system include , limited , cardiorespiratory sign mucosal and/or skin change ( e.g . angioedema , etc ) present rapidly progress severe lifethreatening reaction . Have rash , dermatologic condition tattoo may interfere injection site reaction rating Have receive blood product ( e.g . blood transfusion immunoglobulin within 90 day vaccination study Have donate one unit blood ( approximately 450 mL ) plasma within 30 day vaccination study Have receive live vaccine within 4 week inactivate vaccine subunit vaccine within 2 week prior vaccination study Have functional surgical asplenia Have positive urine drug screen ( unless subject currently prescribe drug detect license health care provider continue administration drug would otherwise exclude subject participation ) Have know suspect problem alcohol drug abuse Were administer investigational drug within six week prior study entry Are concurrently participate clinical study include administration investigational product Are member team conducting study Are dependent relationship study Investigator study team member . Dependent relationship include close relative ( i.e . child , partner/spouse , sibling , parent ) well employee Investigator site conduct study If female : pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>